Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma

The use of immune checkpoint inhibitors in malignant tumors improves patient outcomes. Because single-agent immune checkpoint blockade has a low objective response rate, it is meaningful to explore the combined blockade of immune checkpoint receptors. We aimed to investigate the co-expression of TIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaolin, Feng, Yaning, Fan, Peiwen, Dong, Danning, Yao, Xuan, Peng, Yanchun, Wang, Ruozheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351092/
https://www.ncbi.nlm.nih.gov/pubmed/36913701
http://dx.doi.org/10.17305/bb.2022.8562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351092/
https://www.ncbi.nlm.nih.gov/pubmed/36913701
http://dx.doi.org/10.17305/bb.2022.8562

Ejemplares similares